ActivePhase 2ACTRN12610000400066

A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects with Type 2 Diabetes Mellitus

A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects with Type 2 Diabetes Mellitus

Sponsor

ChemoCentryx, Inc.

Enrollment

140 participants

Start Date

Jan 29, 2010

Study Type

Interventional

Conditions

Type 2 Diabetes Mellitus

Summary

The purpose of this study is to evaluate the safety and potential effectiveness of CCX140-B in subjects with type 2 diabetes mellitus.

Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 65 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests a new drug called CCX140-B for people with type 2 diabetes. It is for adults aged 18 to 65 who are already taking metformin but still have blood sugar levels that are not well controlled. Participants must have a BMI of at least 25.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

CCX140-B capsules 5 mg once daily for 28 days (Group C); CCX140-B capsules 10 mg once daily for 28 days (Group D)

Locations(4)

New Zealand

Czech Republic

Germany

Hungary

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12610000400066

Related Trials

POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes.

NCT074331921 location

A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study)

NCT073552704 locations

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

NCT058814471 location

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

NCT0735105836 locations

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

NCT072325371 location